Chun-Pai Yang Selected Research

Cluster Headache (Cluster Headaches)

9/2011

[Treatment guidelines for acute and preventive treatment of cluster headache].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Pai Yang Research Topics

Disease

15	Migraine Disorders (Migraine) 03/2024 - 11/2013
4	Carpal Tunnel Syndrome 07/2021 - 05/2009
3	Headache (Headaches) 03/2024 - 01/2022
3	Stroke (Strokes) 01/2021 - 01/2019
2	Post-Acute COVID-19 Syndrome 08/2023 - 01/2022
2	COVID-19 08/2023 - 01/2022
2	Dementia (Dementias) 10/2022 - 01/2022
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 09/2017
2	Cognitive Dysfunction 01/2022 - 10/2020
2	Pain (Aches) 10/2021 - 05/2009
2	Ischemic Stroke 01/2021 - 09/2014
2	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2020 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 10/2015
1	Thrombosis (Thrombus) 08/2023
1	Hypoxia (Hypoxemia) 08/2023
1	Neuroinflammatory Diseases 08/2023
1	Migraine with Aura (Familial Hemiplegic Migraine) 09/2022
1	Epilepsy (Aura) 09/2022
1	Brain Infarction 09/2022
1	Hemorrhage 03/2022
1	Edema (Dropsy) 03/2022
1	Brain Ischemia (Cerebral Ischemia) 03/2022
1	Inflammation (Inflammations) 01/2022
1	Chronobiology Disorders (Circadian Rhythm Disorder) 01/2022
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2022
1	Cerebral Small Vessel Diseases 01/2021
1	Nausea 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Vomiting 01/2020
1	Peripheral Arterial Disease 01/2020
1	Delirium 01/2020

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2014
5	Monoclonal AntibodiesIBA 02/2024 - 10/2020
5	Calcitonin Gene-Related PeptideIBA 02/2024 - 10/2020
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2017 - 09/2014
3	Tryptamines (Triptans)IBA 09/2022 - 01/2020
3	lasmiditanIBA 10/2021 - 01/2020
3	SteroidsIBA 07/2021 - 05/2009
2	Eicosapentaenoic AcidIBA 03/2024 - 12/2023
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2024 - 01/2022
2	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 02/2024 - 03/2021
2	Neurotransmitter Agents (Neurotransmitter)IBA 08/2023 - 01/2022
2	Particulate MatterIBA 10/2022 - 01/2021
2	Topiramate (Topamax)FDA LinkGeneric 09/2022 - 11/2013
2	MelatoninIBA 01/2022 - 09/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
2	5-HT1F Serotonin ReceptorIBA 03/2021 - 01/2020
2	NAD (NADH)IBA 03/2017 - 10/2015
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2024
1	atogepantIBA 02/2024
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2023
1	Docosahexaenoic AcidsIBA 12/2023
1	Vitamin D FDA LinkGeneric 08/2023
1	Hormones (Hormone)IBA 08/2023
1	Amitriptyline (Elavil)FDA LinkGeneric 09/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2022
1	Antidepressive Agents (Antidepressants)IBA 09/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2022
1	FlunarizineIBA 09/2022
1	Propranolol (Inderal)FDA LinkGeneric 09/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 09/2022
1	Type A Botulinum Toxins (Botox)FDA Link 09/2022
1	Streptozocin (Streptozotocin)FDA Link 03/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2022
1	LipidsIBA 01/2022
1	CytokinesIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Polymethyl Methacrylate (Sol)IBA 01/2022
1	ORALIT (ORS)IBA 10/2021
1	rimegepant sulfateIBA 10/2021
1	eptinezumabIBA 10/2021
1	ubrogepantIBA 10/2021
1	erenumabIBA 10/2021
1	salicylhydroxamic acid (SHAM)IBA 05/2021
1	Nasal SpraysIBA 03/2021
1	Sumatriptan (Imigran)FDA LinkGeneric 03/2021
1	Excipients (Suspending Agents)IBA 03/2021
1	DFN-02IBA 03/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Blood Glucose (Blood Sugar)IBA 10/2020
1	Peptides (Polypeptides)IBA 10/2020
1	tau Proteins (tau Protein)IBA 10/2020
1	Amyloid (Amyloid Fibrils)IBA 10/2020
1	galcanezumabIBA 10/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	4- fluoro- N- (3- (1- methyl- 4- piperidinyl)- 1H- indol- 5- yl)benzamideIBA 01/2020
1	5-HT1D Serotonin ReceptorIBA 01/2020

Therapy/Procedure

5	Therapeutics 09/2022 - 09/2017
2	Complementary Therapies (Alternative Medicine) 09/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 03/2021 - 09/2020
1	Contraindications 09/2022
1	Controlled Hypotension 03/2022
1	Aftercare (After-Treatment) 01/2022
1	Phototherapy (Light Therapy) 01/2022
1	Institutionalization (Institutionalized Persons) 01/2022
1	Acupuncture Points (Acupuncture Point) 05/2021
1	Secondary Prevention 01/2021
1	Lasers (Laser) 10/2019